Insider trade

Director sold ~$101K of CHE shares in the open market

Traded Jul 31, 2026 · Filed Aug 3, 2026

Why it stands out

A board member of Chemed sold $101K of Chemed shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$101,080

Shares × reported transaction price

Timing vs results

3 days after results of Jul 28, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−0.5%	−0.1%	−0.4%
30 days	−2.8%	+0.2%	−3.1%

Past results only. Not a forecast.

Officer sold

6w ago

Chemed's executive vice president sold $541K of Chemed shares. Nobody planned it ahead of time.

CEO sold

6w ago

The boss of Chemed sold $1.08M of Chemed shares. Nobody planned it ahead of time.

8w ago

Derivative exercise or conversion — not an open-market buy.